ELVN - Enliven Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ELVN (1672619)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
53 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-03-25
ELVNKintz SamuelPres, CEOS - Sale+OE$17.56-12,0001,264,587-1%-$210,661
D
2024-03-20
ELVNBallal Rahul D.DirS - Sale+OE$19.16-13,27822,341-37%-$254,462
2024-03-19
ELVNHeyman Richard A.DirS - Sale$14.50-1,270210,093-1%-$18,419
2024-03-06
ELVNPatel AnishCOOS - Sale$15.64-4,875401,499-1%-$76,239
D
2024-02-29
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$16.42-12,0001,117,035-1%-$197,006
D
2024-02-27
ELVNHohl BenjaminCFOS - Sale+OE$16.97-3,2500-100%-$55,163
2024-02-15
ELVNHeyman Richard A.DirS - Sale$17.42-1,270211,363-1%-$22,117
2024-02-14
ELVN5Am Partners Vi, LLC10%S - Sale$14.90-825,0003,835,975-18%-$12,292,500
2024-02-06
ELVNPatel AnishCOOS - Sale$15.11-4,875406,374-1%-$73,658
2024-01-31
ELVN5Am Partners Vi, LLC10%S - Sale$15.00-500,0004,660,975-10%-$7,500,000
2024-01-30
ELVNHeyman Richard A.DirS - Sale$16.41-1,270212,633-1%-$20,840
D
2024-01-29
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$15.85-12,0001,117,035-1%-$190,256
D
2024-01-29
ELVNHohl BenjaminCFOS - Sale+OE$15.81-3,2500-100%-$51,388
D
2024-01-25
ELVNKintz SamuelPres, CEOS - Sale+OE$15.69-12,0001,264,587-1%-$188,229
2024-01-22
ELVNPatel AnishCOOS - Sale$15.14-4,875411,249-1%-$73,783
D
2023-12-29
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$14.28-12,0001,117,035-1%-$171,381
M
2023-12-28
ELVNPatel AnishCOOS - Sale$15.02-13,540416,124-3%-$203,348
DM
2023-12-28
ELVNHohl BenjaminCFOS - Sale+OE$15.02-11,8700-100%-$178,327
D
2023-12-26
ELVNKintz SamuelPres, CEOS - Sale+OE$14.64-12,0001,264,587-1%-$175,709
M
2023-12-22
ELVNPatel AnishCOOS - Sale$15.03-1,085429,6640%-$16,306
DM
2023-12-22
ELVNHohl BenjaminCFOS - Sale+OE$15.07-1,1300-100%-$17,025
DM
2023-12-21
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$13.07-6,5661,117,035-1%-$85,790
DM
2023-12-21
ELVNKintz SamuelPres, CEOS - Sale+OE$13.05-8,1951,264,587-1%-$106,915
M
2023-12-21
ELVNHeyman Richard A.DirS - Sale$13.00-216213,9030%-$2,808
D
2023-12-20
ELVNKintz SamuelPres, CEOS - Sale+OE$13.01-7,7791,264,587-1%-$101,238
DM
2023-12-19
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$13.01-8,8881,117,035-1%-$115,646
M
2023-12-19
ELVNHeyman Richard A.DirS - Sale$13.02-4,280214,119-2%-$55,727
D
2023-11-03
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$13.08-8,5461,117,035-1%-$111,751
D
2023-11-03
ELVNKintz SamuelPres, CEOS - Sale+OE$13.08-8,0261,264,587-1%-$104,999
D
2023-09-29
ELVNLyssikatos Joseph PChief Scientific OfficerS - Sale+OE$13.62-12,0001,117,035-1%-$163,498
2023-09-26
ELVN5Am Partners Vi, LLC10%S - Sale$15.00-197,5005,160,975-4%-$2,962,500
D
2023-09-25
ELVNKintz SamuelPres, CEOS - Sale+OE$13.81-12,0001,264,587-1%-$165,691
2023-08-24
ELVN5Am Partners Vi, LLC10%S - Sale$16.00-440,0005,358,475-8%-$7,040,000
2023-02-23
ELVNCommodore Capital LP10%P - Purchase$22.07+6221,448,6400%+$13,723
M
2023-02-21
IMRACommodore Capital LP10%P - Purchase$5.15+31,7592,872,513+1%+$163,498
2023-02-22
IMRAGray MichaelCFO, COOS - Sale$4.67-9,85627,610-26%-$46,028
2023-02-22
IMRABallal Rahul D.CEOS - Sale$4.66-32,86187,835-27%-$153,132
2023-01-30
IMRAGray MichaelCFO, COOS - Sale$3.92-3,59637,466-9%-$14,096
2023-01-30
IMRABallal Rahul D.CEOS - Sale$3.91-11,313120,696-9%-$44,234
A
2023-01-03
IMRALeonard Braden Michael10%S - Sale$4.00-1,250,0001,997,774-38%-$5,000,000
2023-01-03
IMRARa Capital Management, L.P.10%P - Purchase$4.00+629,2973,880,021+19%+$2,516,055
2023-01-04
IMRALeonard Braden Michael10%S - Sale$4.00-1,250,0001,997,774-38%-$5,000,000
2022-12-30
IMRALeonard Braden Michael10%S - Sale$4.04-20,0003,247,774-1%-$80,800
M
2022-12-28
IMRALeonard Braden Michael10%S - Sale$4.04-20,0003,267,774-1%-$80,800
M
2022-12-22
IMRALeonard Braden Michael10%S - Sale$4.06-50,0003,287,774-1%-$203,000
M
2022-12-08
IMRARa Capital Management, L.P.10%P - Purchase$3.87+29,8993,250,724+1%+$115,595
M
2022-10-20
IMRARa Capital Management, L.P.10%P - Purchase$3.92+85,9023,220,825+3%+$336,812
M
2022-10-17
IMRARa Capital Management, L.P.10%P - Purchase$3.68+506,1973,134,923+19%+$1,860,961
2022-06-16
IMRALeonard Braden Michael10%P - Purchase$1.11+83,1993,337,774+3%+$92,243
M
2022-06-03
IMRALeonard Braden Michael10%P - Purchase$1.14+33,4303,254,575+1%+$38,027
M
2022-05-16
IMRALeonard Braden Michael10%P - Purchase$1.23+41,1453,221,145+1%+$50,413
M
2022-04-21
IMRALeonard Braden Michael10%P - Purchase$1.40+560,0003,180,000+21%+$783,840
M
2022-04-05
IMRANew Enterprise Associates 14, L.P.10%S - Sale$1.08-694,5512,611,050-21%-$751,256

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top